[1]
Russo A,D'Onofrio F,Conte F,Petretta V,Tedeschi G,Tessitore A, Post-traumatic headaches: a clinical overview. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2014 May;
[PubMed PMID: 24867854]
Level 3 (low-level) evidence
[2]
Ashina H,Porreca F,Anderson T,Amin FM,Ashina M,Schytz HW,Dodick DW, Post-traumatic headache: epidemiology and pathophysiological insights. Nature reviews. Neurology. 2019 Oct;
[PubMed PMID: 31527806]
[3]
Theeler BJ,Flynn FG,Erickson JC, Headaches after concussion in US soldiers returning from Iraq or Afghanistan. Headache. 2010 Sep;
[PubMed PMID: 20553333]
[4]
D'Onofrio F,Russo A,Conte F,Casucci G,Tessitore A,Tedeschi G, Post-traumatic headaches: an epidemiological overview. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2014 May;
[PubMed PMID: 24867867]
Level 2 (mid-level) evidence
[5]
Faux S,Sheedy J, A prospective controlled study in the prevalence of posttraumatic headache following mild traumatic brain injury. Pain medicine (Malden, Mass.). 2008 Nov;
[PubMed PMID: 18266807]
[6]
Schwedt TJ,Chong CD,Peplinski J,Ross K,Berisha V, Persistent post-traumatic headache vs. migraine: an MRI study demonstrating differences in brain structure. The journal of headache and pain. 2017 Aug 22;
[PubMed PMID: 28831776]
[7]
Chen SP,Ay I,de Morais AL,Qin T,Zheng Y,Sadeghian H,Oka F,Simon B,Eikermann-Haerter K,Ayata C, Vagus nerve stimulation inhibits cortical spreading depression. Pain. 2016 Apr;
[PubMed PMID: 26645547]
Level 2 (mid-level) evidence
[8]
Cozzolino O,Marchese M,Trovato F,Pracucci E,Ratto GM,Buzzi MG,Sicca F,Santorelli FM, Understanding Spreading Depression from Headache to Sudden Unexpected Death. Frontiers in neurology. 2018;
[PubMed PMID: 29449828]
Level 3 (low-level) evidence
[9]
Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain : a journal of neurology. 2003 Aug:126(Pt 8):1801-13
[PubMed PMID: 12821523]
[10]
Piovesan EJ,Kowacs PA,Oshinsky ML, Convergence of cervical and trigeminal sensory afferents. Current pain and headache reports. 2003 Oct;
[PubMed PMID: 12946291]
[11]
Piantino J,Lim MM,Newgard CD,Iliff J, Linking Traumatic Brain Injury, Sleep Disruption and Post-Traumatic Headache: a Potential Role for Glymphatic Pathway Dysfunction. Current pain and headache reports. 2019 Jul 29;
[PubMed PMID: 31359173]
[13]
Schwedt TJ, Structural and Functional Brain Alterations in Post-traumatic Headache Attributed to Mild Traumatic Brain Injury: A Narrative Review. Frontiers in neurology. 2019;
[PubMed PMID: 31258507]
Level 3 (low-level) evidence
[14]
Douglas AC,Wippold FJ 2nd,Broderick DF,Aiken AH,Amin-Hanjani S,Brown DC,Corey AS,Germano IM,Hadley JA,Jagadeesan BD,Jurgens JS,Kennedy TA,Mechtler LL,Patel ND,Zipfel GJ, ACR Appropriateness Criteria Headache. Journal of the American College of Radiology : JACR. 2014 Jul;
[PubMed PMID: 24933450]
[15]
Quinlan C, Patient-Friendly Summary of the ACR Appropriateness Criteria Headache. Journal of the American College of Radiology : JACR. 2018 Mar;
[PubMed PMID: 29352715]
[16]
Fraser F,Matsuzawa Y,Lee YSC,Minen M, Behavioral Treatments for Post-Traumatic Headache. Current pain and headache reports. 2017 May;
[PubMed PMID: 28283812]
[17]
Larsen EL,Ashina H,Iljazi A,Al-Khazali HM,Seem K,Ashina M,Ashina S,Schytz HW, Acute and preventive pharmacological treatment of post-traumatic headache: a systematic review. The journal of headache and pain. 2019 Oct 21;
[PubMed PMID: 31638888]
Level 1 (high-level) evidence
[18]
Jia C,Lucchese S,Zhang F,Govindarajan R, The Role of Onabotulinum Toxin Type A in the Management of Chronic Non-migraine Headaches. Frontiers in neurology. 2019;
[PubMed PMID: 31616362]
[19]
Conidi FX, Interventional Treatment for Post-traumatic Headache. Current pain and headache reports. 2016 Jun;
[PubMed PMID: 27130542]
[20]
Schoenen J, Guidelines for trials of drug treatments in tension-type headache. First edition: International Headache Society Committee on Clinical Trials. Cephalalgia : an international journal of headache. 1995 Jun;
[PubMed PMID: 7553803]
[21]
Packman E,Packman B,Thurston H,Tseng L, Lumiracoxib is effective in the treatment of episodic tension-type headache. Headache. 2005 Oct;
[PubMed PMID: 16178946]
[22]
Bettucci D,Testa L,Calzoni S,Mantegazza P,Viana M,Monaco F, Combination of tizanidine and amitriptyline in the prophylaxis of chronic tension-type headache: evaluation of efficacy and impact on quality of life. The journal of headache and pain. 2006 Feb;
[PubMed PMID: 16514501]
Level 2 (mid-level) evidence
[23]
Bendtsen L,Buchgreitz L,Ashina S,Jensen R, Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache. European journal of neurology. 2007 Feb;
[PubMed PMID: 17250728]
[24]
Barbanti P,Egeo G,Aurilia C,Fofi L, Treatment of tension-type headache: from old myths to modern concepts. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2014 May;
[PubMed PMID: 24867829]
[25]
Burch R, Migraine and Tension-Type Headache: Diagnosis and Treatment. The Medical clinics of North America. 2019 Mar;
[PubMed PMID: 30704678]
[26]
Forssell H,Kalso E,Koskela P,Vehmanen R,Puukka P,Alanen P, Occlusal treatments in temporomandibular disorders: a qualitative systematic review of randomized controlled trials. Pain. 1999 Dec;
[PubMed PMID: 10568864]
Level 2 (mid-level) evidence
[27]
Pihut M,Ferendiuk E,Szewczyk M,Kasprzyk K,Wieckiewicz M, The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache. The journal of headache and pain. 2016;
[PubMed PMID: 27011213]
[28]
Holland S,Silberstein SD,Freitag F,Dodick DW,Argoff C,Ashman E, Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012 Apr 24;
[PubMed PMID: 22529203]
Level 2 (mid-level) evidence
[29]
Pringsheim T,Becker WJ, Triptans for symptomatic treatment of migraine headache. BMJ (Clinical research ed.). 2014 Apr 7;
[PubMed PMID: 24711666]
[32]
Silberstein SD,Holland S,Freitag F,Dodick DW,Argoff C,Ashman E, Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012 Apr 24;
[PubMed PMID: 22529202]
Level 2 (mid-level) evidence
[33]
Simpson DM,Hallett M,Ashman EJ,Comella CL,Green MW,Gronseth GS,Armstrong MJ,Gloss D,Potrebic S,Jankovic J,Karp BP,Naumann M,So YT,Yablon SA, Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2016 May 10;
[PubMed PMID: 27164716]
Level 1 (high-level) evidence
[35]
Linde M,Hagen K,Salvesen Ø,Gravdahl GB,Helde G,Stovner LJ, Onabotulinum toxin A treatment of cervicogenic headache: a randomised, double-blind, placebo-controlled crossover study. Cephalalgia : an international journal of headache. 2011 May;
[PubMed PMID: 21300635]
Level 1 (high-level) evidence
[37]
Kang J,Yang P,Zang Q,He X, Traumatic neuroma of the superficial peroneal nerve in a patient: a case report and review of the literature. World journal of surgical oncology. 2016 Sep 10;
[PubMed PMID: 27613606]
Level 3 (low-level) evidence
[38]
Chaibi A,Russell MB, Manual therapies for cervicogenic headache: a systematic review. The journal of headache and pain. 2012 Jul;
[PubMed PMID: 22460941]
Level 1 (high-level) evidence
[39]
Racicki S,Gerwin S,Diclaudio S,Reinmann S,Donaldson M, Conservative physical therapy management for the treatment of cervicogenic headache: a systematic review. The Journal of manual
[PubMed PMID: 24421621]
Level 1 (high-level) evidence
[40]
Hamer JF,Purath TA, Response of cervicogenic headaches and occipital neuralgia to radiofrequency ablation of the C2 dorsal root ganglion and/or third occipital nerve. Headache. 2014 Mar;
[PubMed PMID: 24433241]
[41]
Xiao H,Peng B,Ma K,Huang D,Liu X,Lu Y,Liu Q,Lu L,Liu J,Li Y,Song T,Tao W,Shen W,Yang X,Wang L,Zhang X,Zhuang Z,Liu H,Liu Y, The Chinese Association for the Study of Pain (CASP): Expert Consensus on the Cervicogenic Headache. Pain research
[PubMed PMID: 31065305]
Level 3 (low-level) evidence
[43]
Hoffman JM,Lucas S,Dikmen S,Braden CA,Brown AW,Brunner R,Diaz-Arrastia R,Walker WC,Watanabe TK,Bell KR, Natural history of headache after traumatic brain injury. Journal of neurotrauma. 2011 Sep;
[PubMed PMID: 21732765]
[44]
Lucas S,Hoffman JM,Bell KR,Dikmen S, A prospective study of prevalence and characterization of headache following mild traumatic brain injury. Cephalalgia : an international journal of headache. 2014 Feb;
[PubMed PMID: 23921798]
[45]
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia : an international journal of headache. 2018 Jan;
[PubMed PMID: 29368949]